<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04235231</url>
  </required_header>
  <id_info>
    <org_study_id>RHL-NICU-2020-01</org_study_id>
    <nct_id>NCT04235231</nct_id>
  </id_info>
  <brief_title>The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance Tomography</brief_title>
  <acronym>N-LAT-EIT</acronym>
  <official_title>The Effect of Lateral Tilt on Ventilation Distribution in Lungs Assessed by Electrical Impedance Tomography: A Pilot Prospective Randomized Study in Neurocritical Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Liberec</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technology Agency of the Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regional Hospital Liberec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevention of lung inhomogeneity is an essential part of preventive strategy in neurocritical
      care, reducing the risks of secondary brain damage from hypoxemia, hypo/hypercapnia or
      pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the monocentric, intervention, prospective, randomized study, the investigators will
      examine the effect of lateral tilting (routinely used in critical care) on the lung
      inhomogeneity that will be analyzed by electrical impedance tomography (EIT) in the
      unconscious patients with acute primary brain disease and artificial pulmonary ventilation.
      Two types of lateral tilting will be compared: manual positioning of body by nurse versus the
      bed tilting (15° lateral tilt, original company (LINET) and product brand name (Eleganza 5).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Research Randomizer</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Atelectasis/collapse</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Assessed by electrical impedance tomography (EIT) or chest x-ray (CXR) at end of observation period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluating oxygenation parameters</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluating hemodynamic parameters</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Hemodynamic monitoring: stroke volume variation (SVV)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness measurement between two groups</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Therapeutic Intervention Scoring System (TISS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Profiling pneumonia incidence</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Pneumonia score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparing duration of stay in Neurocenter Neurointensive Care Unit</measure>
    <time_frame>up to 24 weeks</time_frame>
    <description>Days of hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Lung Collapse</condition>
  <arm_group>
    <arm_group_label>Lateral tilt bed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bed tilting (15° lateral tilt, original product brand name LINET Eleganza 5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Body positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Manual positioning of body by nurse.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bed tilting</intervention_name>
    <description>15° lateral tilt, original product brand name LINET Eleganza 5</description>
    <arm_group_label>Lateral tilt bed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body positioning</intervention_name>
    <description>Manual positioning of body by nurse: left side, back, right side, using positioning pillows</description>
    <arm_group_label>Body positioning</arm_group_label>
    <other_name>Manual positioning of body by nurse</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary brain disease

          -  Hospitalization in Neurocenter, Neurointensive Care Unit

          -  Age&gt;18 years

          -  Unconsciousness

          -  Artificial pulmonary ventilation

        Exclusion Criteria:

          -  Intracranial hypertension

          -  History of primary lung disease

          -  The terminal stage of the disease

          -  Refractory hemodynamic instability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vera Spatenkova, MD, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Neurocenter</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vera Spatenkova, MD, Ph.D.</last_name>
    <phone>00420 724 027 126</phone>
    <email>vera.spatenkova@nemlib.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vendula Machackova, MSc., Ph.D.</last_name>
    <phone>00420 724 600 739</phone>
    <email>vendula.machackova@nemlib.cz</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>June 10, 2020</last_update_submitted>
  <last_update_submitted_qc>June 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regional Hospital Liberec</investigator_affiliation>
    <investigator_full_name>Vera Spatenkova, MD, Ph.D.</investigator_full_name>
    <investigator_title>Head of Neurocenter</investigator_title>
  </responsible_party>
  <keyword>Lung Inhomogeneity</keyword>
  <keyword>Lung Collapse</keyword>
  <keyword>Atelectasis</keyword>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>EIT</keyword>
  <keyword>Bed tilting</keyword>
  <keyword>Positioning</keyword>
  <keyword>Neurocritical Care</keyword>
  <keyword>Unconsciousness</keyword>
  <keyword>Acute Brain Disease</keyword>
  <keyword>Preventive Strategy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Atelectasis</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 7, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/31/NCT04235231/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

